Medicine and Dentistry
Neoplasm
100%
Ganglioglioma
49%
Glioblastoma
35%
Pediatrics
30%
Intracranial Tumor
28%
Neurofibromatosis Type I
23%
Malignant Peripheral Nerve Sheath Tumor
23%
Disease
20%
Meningioma
19%
Overall Survival
19%
Diagnosis
19%
Surgery
17%
Tumor Progression
17%
Central Nervous System
16%
Breast Cancer
15%
Radiation Therapy
12%
Microglia
12%
Neuroepithelioma
11%
Epidermal Growth Factor Receptor
11%
Magnetic Resonance Imaging
10%
Tumor Cell
10%
Central Nervous System Tumor
10%
Gene Mutation
10%
Ependymoma
9%
Recurrent Disease
9%
Immunotherapy
9%
Carcinogenesis
8%
Metastatic Carcinoma
8%
Papilloma
7%
Targeted Therapy
7%
Biopsy Technique
7%
Protein Expression
7%
Plexiform Neurofibroma
7%
Breast Tumor
6%
Chemotherapy
6%
Melanoma
6%
T Cell
6%
Oligoastrocytoma
6%
Malignant Neoplasm
6%
Cerebrospinal Fluid
6%
Morphology
6%
Connective Tissue Cancer
5%
Progression Free Survival
5%
Metastatic Melanoma
5%
Transcriptional Regulator ATRX
5%
Choroid Plexus Papilloma
5%
Tuberous Sclerosis
5%
Subependymal Giant Cell Astrocytoma
5%
Cancer Growth
5%
Tamoxifen
5%
Keyphrases
Tumor
70%
Glioblastoma
44%
Neurofibromatosis Type 1 (NF-1)
38%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
30%
Neurofibromatosis Type I
30%
Glioma
26%
Meningioma
23%
Brain Tumor
20%
Overall Survival
20%
Central Nervous System Tumors
16%
Histopathological Features
14%
Low-grade Glioma
13%
Pediatric Glioma
12%
Tumor Growth
12%
Pediatric
11%
Germ Cells
11%
BRAF V600E mutation
11%
Central Nervous System
11%
Copy number Variation
11%
Isocitrate Dehydrogenase 1 (IDH1)
11%
Clinical Features
10%
Genetic Modification
10%
Glioma Growth
10%
Tumor Cells
9%
Tumor Protein p53 (TP53)
8%
ATRX mutation
8%
Knockdown
8%
Cerebrospinal Fluid
8%
Clinical Outcomes
8%
Optic Pathway Glioma
8%
BRAF Alteration
8%
Subventricular Zone
8%
HOXB13
8%
Temporal Lobe
8%
Molecular Diagnostics
8%
Progression-free Survival
8%
Recurrence-free Survival
7%
Microglia
7%
Targeted Therapy
7%
BRAF Inhibitor (BRAFi)
7%
Diffuse Glioma
7%
Ependymoma
7%
Prognostic Marker
7%
Pilocytic Astrocytoma
7%
Ganglioglioma
7%
Resection
7%
Non-neoplastic
7%
Genomic Profiling
7%
Chemotherapy
7%
Immunohistochemistry
7%